EVOLUS, INC. Payments of Stock Issuance Costs
EVOLUS, INC. (EOLS) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-03
- EVOLUS, INC. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00.
- EVOLUS, INC. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- EVOLUS, INC. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00.
- EVOLUS, INC. payments of stock issuance costs for the quarter ending 2024-09-30 was $0.00.
- EVOLUS, INC. payments of stock issuance costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- EVOLUS, INC. payments of stock issuance costs for fiscal 2024 was $248.00K.
- EVOLUS, INC. payments of stock issuance costs for fiscal 2023 was $0.00.
- EVOLUS, INC. payments of stock issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $248.00K 10-K · filed 2026-03-03 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $248.00K 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $248.00K 10-Q · filed 2025-08-05 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-07-31 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $0.00 derived: sum of 2 quarters · filed 2025-03-04 | $0.00 10-K · filed 2025-03-04 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $214.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $214.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $214.00K 10-Q · filed 2022-08-02 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $0.00 derived: sum of 2 quarters · filed 2022-03-03 | $0.00 10-K · filed 2022-03-03 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | |||
| 2019-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $203.00K derived: sum of 2 quarters · filed 2021-03-25 | $203.00K derived: sum of 3 quarters · filed 2021-03-25 | $203.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $300.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $300.00K derived: sum of 3 quarters · filed 2020-02-25 | $374.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $300.00K derived: sum of 2 quarters · filed 2020-02-25 | $374.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.06M 10-K · filed 2020-02-25 |
| 2018-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $374.00K derived: sum of 2 quarters · filed 2019-11-04 | $1.06M 10-Q · filed 2019-11-04 | $2.35M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $760.00K 10-Q · filed 2019-08-12 | $2.05M derived: sum of 3 quarters · filed 2019-08-12 | $2.05M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $686.00K 10-Q · filed 2019-05-01 | $1.97M derived: sum of 2 quarters · filed 2019-05-01 | $1.97M derived: sum of 3 quarters · filed 2019-05-01 | |
| 2017-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $1.29M derived: sum of 2 quarters · filed 2019-03-20 | $1.29M 10-K · filed 2019-03-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |